These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10321935

  • 1. Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.
    Buckler H, Fraser W, Hosking D, Ryan W, Maricic MJ, Singer F, Davie M, Fogelman I, Birbara CA, Moses AM, Lyles K, Selby P, Richardson P, Seaman J, Zelenakas K, Siris E.
    Bone; 1999 May; 24(5 Suppl):81S-85S. PubMed ID: 10321935
    [No Abstract] [Full Text] [Related]

  • 2. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer V, Zelenakas K.
    Calcif Tissue Int; 1997 May; 60(5):415-8. PubMed ID: 9115157
    [Abstract] [Full Text] [Related]

  • 3. Ibandronate treatment in Paget's disease of bone.
    Grauer A, Heichel S, Knaus J, Dosch E, Ziegler R.
    Bone; 1999 May; 24(5 Suppl):87S-89S. PubMed ID: 10321936
    [No Abstract] [Full Text] [Related]

  • 4. Zoledronate treatment in active Paget's disease.
    Chung G, Keen RW.
    Ann Rheum Dis; 2003 Mar; 62(3):275-6. PubMed ID: 12594123
    [No Abstract] [Full Text] [Related]

  • 5. Zoledronate in the treatment of Paget's disease.
    Siris E.
    Br J Clin Pract Suppl; 1996 Sep; 87():19-20; discussion 22. PubMed ID: 8995014
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F.
    Clin Exp Rheumatol; 2007 Sep; 25(3):464-6. PubMed ID: 17631747
    [Abstract] [Full Text] [Related]

  • 12. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
    Stuckey BG, Gutteridge DH, Stewart GO, Prince RL, Ward LC, Kent GN, Prince RI, Retallack RW, Bhagat CI, Nicholson GC.
    Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM.
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD, Hawthorne AB, Kerr D, Webster G, Hosking DJ.
    J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM, Scott LJ.
    Drugs; 2007 Dec; 67(5):793-804. PubMed ID: 17385948
    [Abstract] [Full Text] [Related]

  • 20. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K, Merry P, Scott DG.
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.